AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12 | +200.0% | 971 | +179.8% | 0.01% | +200.0% |
Q2 2023 | $4 | -83.3% | 347 | -83.7% | 0.00% | -85.7% |
Q1 2023 | $24 | – | 2,123 | +4725.0% | 0.02% | – |
Q4 2022 | $0 | -100.0% | 44 | -97.8% | 0.00% | -100.0% |
Q3 2022 | $21,000 | – | 2,044 | +5577.8% | 0.02% | – |
Q2 2022 | $0 | – | 36 | -21.7% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 46 | -19.3% | 0.00% | -100.0% |
Q4 2021 | $1,000 | – | 57 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |